Description:
Fleming Suspension 457 is a prescription antibiotic medication used to treat bacterial infections in both adults and children. It is particularly effective for respiratory tract infections, skin infections, and other conditions caused by susceptible bacteria.

Prescription:

• Prescription

Dosage:

• Children: Dosage varies based on body weight (recommended by the doctor).
• Adults: Dosage as prescribed by the healthcare professional.
• Administered orally, typically 1-2 times daily with or without food.

Therapeutic Category:

• Antibiotic (Penicillin-class).

Active Ingredients/Composition:

• Amoxicillin (400 mg): Broad-spectrum antibiotic.
• Clavulanic Acid (57 mg): Beta-lactamase inhibitor that enhances the effectiveness of amoxicillin.

Variant:

• Available as a 457 mg/5ml suspension.

Consume Type:

• Oral suspension.

Directions/Usage:

1. Shake the bottle well before use.
2. Use the measuring cup or spoon provided for accurate dosing.
3. Administer at evenly spaced intervals for consistent blood levels.
4. Complete the full course of treatment even if symptoms improve.

Common Side Effects:

• Nausea and vomiting.
• Diarrhea.
• Mild skin rash or itching.
• Abdominal pain or bloating.
• Headache (rare).

Package Type:

• Comes in a sealed bottle with a child-resistant cap.
• May include a measuring spoon or dropper.

Storage Advice:

• Store at 20°C to 25°C (room temperature).
• After reconstitution (mixing with water), refrigerate and use within the recommended duration (typically 7-14 days).
• Keep out of reach of children.

Safety Advice:

• Do not use if allergic to penicillin or cephalosporins.
• Take the medication as prescribed to avoid antibiotic resistance.
• Consult your doctor if severe side effects, such as allergic reactions or persistent diarrhea, occur.
• Not recommended for viral infections (e.g., cold or flu).

Product Substitutes:

• Augmentin Suspension.
• Clavam Suspension.
• Moxclav Suspension.

Manufacturer/Marketer:

• Fleming Pharmaceuticals 

Country of Origin:

• India